No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪192.81 B‬EUR
‪14.36 B‬EUR
‪43.94 B‬EUR
‪1.75 B‬
Beta (1Y)


Vasant Narasimhan
Employees (FY)
‪76.06 K‬
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Revenue to profit conversion
Debt level and coverage

See all ideas 

Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NOT is 95.97 EUR — it has decreased by 3.68% in the past 24 hours. Watch NOVARTIS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange NOVARTIS INC stocks are traded under the ticker NOT.
We've gathered analysts' opinions on NOVARTIS INC future price: according to them, NOT price has a max estimate of 129.73 EUR and a min estimate of 78.94 EUR. Watch NOT chart and read a more detailed NOVARTIS INC stock forecast: see what analysts think of NOVARTIS INC and suggest that you do with its stocks.
NOT reached its all-time high on Jan 29, 2024 with the price of 100.58 EUR, and its all-time low was 26.44 EUR and was reached on Mar 4, 2009. View more price dynamics on NOT chart.
See other stocks reaching their highest and lowest prices.
NOT stock is 5.81% volatile and has beta coefficient of 0.78. Track NOVARTIS INC stock price on the chart and check out the list of the most volatile stocks — is NOVARTIS INC there?
Today NOVARTIS INC has the market capitalization of ‪190.45 B‬, it has decreased by 0.51% over the last week.
Yes, you can track NOVARTIS INC financials in yearly and quarterly reports right on TradingView.
NOVARTIS INC is going to release the next earnings report on Oct 29, 2024. Keep track of upcoming events with our Earnings Calendar.
NOT earnings for the last quarter are 1.84 EUR per share, whereas the estimation was 1.73 EUR resulting in a 6.46% surprise. The estimated earnings for the next quarter are 1.73 EUR per share. See more details about NOVARTIS INC earnings.
NOVARTIS INC revenue for the last quarter amounts to ‪11.68 B‬ EUR, despite the estimated figure of ‪11.55 B‬ EUR. In the next quarter, revenue is expected to reach ‪11.49 B‬ EUR.
NOT net income for the last quarter is ‪3.05 B‬ EUR, while the quarter before that showed ‪2.41 B‬ EUR of net income which accounts for 26.27% change. Track more NOVARTIS INC financial stats to get the full picture.
Yes, NOT dividends are paid annually. The last dividend per share was 3.43 EUR. As of today, Dividend Yield (TTM)% is 3.50%. Tracking NOVARTIS INC dividends might help you take more informed decisions.
NOVARTIS INC dividend yield was 3.89% in 2023, and payout ratio reached 51.36%. The year before the numbers were 3.83% and 105.08% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 21, 2024, the company has ‪76.06 K‬ employees. See our rating of the largest employees — is NOVARTIS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVARTIS INC EBITDA is ‪19.26 B‬ EUR, and current EBITDA margin is 44.33%. See more stats in NOVARTIS INC financial statements.
Like other stocks, NOT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVARTIS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVARTIS INC technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVARTIS INC stock shows the strong buy signal. See more of NOVARTIS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.